REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$828.50 -0.67% As of Aug 24, 9:02 PM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Profit-Taking Watch: REGN Reaches $828.50 on High RSI

Bearish
Aug 24, 2026 at 9:02 PM • $828.50 (-0.67%)

Regeneron Pharmaceuticals Inc (REGN) fell 0.67% to finish at $828.50 on August 24.

From a technical standpoint, the outlook appears mixed:

Moving Averages Price trades above the 9-day EMA ($816.04) with a bullish stack. The 21-day EMA at $781.29 provides support.
Momentum RSI at 73.5 is in overbought territory, suggesting potential near-term exhaustion. MACD is bullish (38.48 vs signal 37.50).
Volatility Bollinger Band width at 20.5% indicates normal volatility.

The bullish trend is intact, but overbought momentum readings suggest waiting for a pullback.

The $704.37-$865.15 range defines near-term boundaries.

Sell Signal? REGN RSI Peaks at $834.04

Bearish
Aug 23, 2026 at 8:32 AM • $834.04 (+0.90%)

REGN Overbought Surge to $834.04 May Stall

Bearish
Aug 22, 2026 at 12:23 AM • $834.04 (+0.90%)

REGN Enters Danger Zone as RSI Spikes at $834.04

Bearish
Aug 21, 2026 at 9:02 PM • $834.04 (+0.90%)

REGN Rally Stretched Thin Near $826.64

Bearish
Aug 20, 2026 at 9:02 PM • $826.64 (-1.69%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $828.50
Daily Change -0.67%
Sentiment Bearish
Sector Biotechnology
Last Updated Aug 24

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.